Startup | October 05, 2021
ResMed acquires home sleep testing company Ectosense
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The consideration for the medicines in India is valued at Rs 180.48 crore
The state-of-the-art facility provides a pathway from development to large-scale biologics production
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
Torrent is one of India's fastest-growing pharma majors
Cipla is a leading global pharma company
The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
Subscribe To Our Newsletter & Stay Updated
